Wealth Enhancement Advisory Services LLC cut its holdings in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 12.4% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 511,669 shares of the healthcare conglomerate's stock after selling 72,642 shares during the quarter. Wealth Enhancement Advisory Services LLC owned about 0.06% of UnitedHealth Group worth $267,991,000 at the end of the most recent quarter.
Other hedge funds also recently modified their holdings of the company. Norges Bank acquired a new stake in UnitedHealth Group in the 4th quarter valued at approximately $6,375,744,000. GAMMA Investing LLC lifted its stake in shares of UnitedHealth Group by 56,142.1% in the first quarter. GAMMA Investing LLC now owns 8,295,153 shares of the healthcare conglomerate's stock valued at $4,344,586,000 after buying an additional 8,280,404 shares during the period. Raymond James Financial Inc. acquired a new position in UnitedHealth Group in the 4th quarter valued at approximately $1,914,740,000. Amundi increased its holdings in UnitedHealth Group by 97.2% in the 4th quarter. Amundi now owns 6,069,100 shares of the healthcare conglomerate's stock valued at $3,183,132,000 after buying an additional 2,991,470 shares during the period. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its holdings in UnitedHealth Group by 36.6% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 8,592,718 shares of the healthcare conglomerate's stock valued at $4,346,712,000 after purchasing an additional 2,301,010 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company's stock.
Insider Buying and Selling
In other news, Director John H. Noseworthy purchased 300 shares of the company's stock in a transaction dated Wednesday, May 14th. The shares were purchased at an average price of $312.16 per share, for a total transaction of $93,648.00. Following the transaction, the director now owns 6,063 shares of the company's stock, valued at approximately $1,892,626.08. This trade represents a 5.21% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, CEO Patrick Hugh Conway sold 589 shares of the company's stock in a transaction on Tuesday, June 10th. The shares were sold at an average price of $305.00, for a total transaction of $179,645.00. Following the sale, the chief executive officer now directly owns 10,398 shares in the company, valued at $3,171,390. This trade represents a 5.36% decrease in their position. The disclosure for this sale can be found here. Insiders have acquired a total of 109,408 shares of company stock valued at $31,607,768 over the last 90 days. 0.28% of the stock is owned by insiders.
UnitedHealth Group Price Performance
UNH stock opened at $306.90 on Thursday. The company's 50-day moving average price is $370.86 and its two-hundred day moving average price is $467.96. UnitedHealth Group Incorporated has a 12 month low of $248.88 and a 12 month high of $630.73. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.71. The firm has a market cap of $278.40 billion, a P/E ratio of 12.85, a P/E/G ratio of 1.45 and a beta of 0.44.
UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a net margin of 5.39% and a return on equity of 26.29%. The business had revenue of $109.58 billion during the quarter, compared to the consensus estimate of $111.56 billion. During the same quarter in the previous year, the business posted $6.91 EPS. On average, analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.
UnitedHealth Group Increases Dividend
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, June 24th. Stockholders of record on Monday, June 16th will be paid a dividend of $2.21 per share. The ex-dividend date of this dividend is Monday, June 16th. This represents a $8.84 annualized dividend and a dividend yield of 2.88%. This is an increase from UnitedHealth Group's previous quarterly dividend of $2.10. UnitedHealth Group's dividend payout ratio (DPR) is presently 37.02%.
Analyst Ratings Changes
UNH has been the subject of several recent analyst reports. JPMorgan Chase & Co. dropped their price objective on shares of UnitedHealth Group from $525.00 to $405.00 and set an "overweight" rating for the company in a report on Thursday, May 15th. Truist Financial reissued a "buy" rating and set a $360.00 price target (down from $580.00) on shares of UnitedHealth Group in a research note on Monday, May 19th. Wolfe Research lowered their price objective on UnitedHealth Group from $501.00 to $390.00 and set an "outperform" rating for the company in a research report on Tuesday, May 20th. Deutsche Bank Aktiengesellschaft cut their price objective on shares of UnitedHealth Group from $521.00 to $362.00 and set a "buy" rating on the stock in a report on Wednesday, May 14th. Finally, Barclays decreased their price objective on UnitedHealth Group to $350.00 and set an "overweight" rating for the company in a research note on Monday, June 2nd. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating and sixteen have issued a buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $426.52.
Check Out Our Latest Stock Analysis on UnitedHealth Group
UnitedHealth Group Profile
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
